BRIEF-Tracon pharmaceuticals announces successful meetings with FDA, EMA for TRC105 in Angiosarcoma
Oct 3 Tracon Pharmaceuticals Inc :
* Reached agreement with both regulatory agencies regarding key elements of phase 3 program for trc105 in angiosarcoma
* Tracon pharmaceuticals announces successful meetings with fda and ema for trc105 (carotuximab) in angiosarcoma
* Expects to initiate enrollment in phase 3 study by year-end Source text for Eikon: Further company coverage:
UPDATE 4-ConocoPhillips sells oil and gas assets to Cenovus for $13.3 bln
CALGARY, Alberta, March 29 ConocoPhillips on Wednesday agreed to sell oil sands and western Canadian natural gas assets to Cenovus Energy Inc for C$17.7 billion ($13.3 billion), making it the latest international oil major to pull back from a region where high costs and low crude prices have made it hard for large companies to make an acceptable return.
UPDATE 3-Amazon plans layoffs at Quidsi unit after losses
March 29 Amazon.com Inc plans to cut 263 jobs at its money-losing parenting products unit Quidsi this summer as part of a business restructuring, it said in a notice filed with New Jersey on Wednesday.